Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation.

Peng, Qiuwei; Wang, Jian; Han, Man; Zhao, Minghong; Li, Kesong; Lu, Tianming; Guo, Qiuyan; Jiang, Quan

Peng, Qiuwei; Wang, Jian; Han, Man; Zhao, Minghong; Li, Kesong; Lu, Tianming; Guo, Qiuyan; Jiang, Quan.

Afiliação

Peng Q; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Wang J; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Han M; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Zhao M; The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.
Li K; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Lu T; School of Public Health, Guangxi Medical University, Guangxi, 530021, China.
Guo Q; Artemisnin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. qyguo@icmm.ac.cn.
Jiang Q; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. jiang.quan@hotmai.com.

Chin Med ; 18(1): 54, 2023 May 15.

Article em En | MEDLINE | ID: mdl-37189204

Palavras-chave

Lactate dehydrogenase; Osteoclast; Reactive oxygen species; Rheumatoid arthritis; Tanshinone IIA

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Chin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China